MedPath

P-11187

Generic Name
P-11187

Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187

Phase 1
Conditions
Overweight
Diabetes Mellitus Type 2 in Obese
Interventions
Drug: Placebo
First Posted Date
2013-06-11
Last Posted Date
2014-08-28
Lead Sponsor
Piramal Enterprises Limited
Target Recruit Count
96
Registration Number
NCT01874366
Locations
🇺🇸

Phase I clinic: MRA Clinical Research, Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath